Literature DB >> 17961551

STAT3 signaling is induced by intercellular adhesion in squamous cell carcinoma cells.

Akiko Onishi1, Qianming Chen, Joseph O Humtsoe, Randall H Kramer.   

Abstract

The signal transducer and activator of transcription-3 (STAT3) frequently activated during tumor progression has been linked to enhanced cell growth. In squamous cell carcinoma of the head and neck (HNSCC), STAT3 signaling has been shown to inhibit apoptosis and induce a more aggressive phenotype through the activation of specific signaling pathways. In the present study, we have examined the potential mechanism by which cell-cell contact initiates STAT3 activation. Using a panel of HNSCC cell lines, Ca(+2)-dependent cell-cell adhesion and adherens junction formation in multicellular aggregates triggered phosphorylation of STAT3-Y705 and STAT1-Y701. This intercellular adhesion-induced STAT3 activation was mediated by JAK and Src signaling and partially by EGFR signaling. In addition, immunolocalization studies revealed initial formation of phosphorylated STAT3-Y705 at nascent E-cadherin cell junctions with eventual translocation to the nucleus in cell aggregates. Adhesion-mediated STAT activation in monolayer and cell aggregate cultures required functional E-cadherin. These results indicate that, in HNSCC cells, cadherin-mediated intercellular adhesion induces STAT signaling that may modulate cell survival and resistance to apoptosis during tumor progression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17961551      PMCID: PMC2766263          DOI: 10.1016/j.yexcr.2007.09.018

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  50 in total

1.  Signaling from E-cadherins to the MAPK pathway by the recruitment and activation of epidermal growth factor receptors upon cell-cell contact formation.

Authors:  S Pece; J S Gutkind
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

2.  Distinct effects of PIAS proteins on androgen-mediated gene activation in prostate cancer cells.

Authors:  M Gross; B Liu; J Tan ; F S French; M Carey; K Shuai
Journal:  Oncogene       Date:  2001-06-28       Impact factor: 9.867

3.  E-cadherin cell-cell adhesion in ewing tumor cells mediates suppression of anoikis through activation of the ErbB4 tyrosine kinase.

Authors:  Hyung-Gyoo Kang; Jasmine M Jenabi; Jingsong Zhang; Nino Keshelava; Hiroyuki Shimada; William A May; Tony Ng; C Patrick Reynolds; Timothy J Triche; Poul H B Sorensen
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

4.  The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5.

Authors:  J D Lord; B C McIntosh; P D Greenberg; B H Nelson
Journal:  J Immunol       Date:  2000-03-01       Impact factor: 5.422

Review 5.  The role of STATs in transcriptional control and their impact on cellular function.

Authors:  J Bromberg; J E Darnell
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

Review 6.  STAT proteins: novel molecular targets for cancer drug discovery.

Authors:  J Turkson; R Jove
Journal:  Oncogene       Date:  2000-12-27       Impact factor: 9.867

7.  Autocrine-mediated activation of STAT3 correlates with cell proliferation in breast carcinoma lines.

Authors:  Li Li; Peter E Shaw
Journal:  J Biol Chem       Date:  2002-02-21       Impact factor: 5.157

8.  Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis.

Authors:  Guilian Niu; Kenneth L Wright; Mei Huang; Lanxi Song; Eric Haura; James Turkson; Shumin Zhang; Tianhong Wang; Dominic Sinibaldi; Domenico Coppola; Richard Heller; Lee M Ellis; James Karras; Jacqueline Bromberg; Drew Pardoll; Richard Jove; Hua Yu
Journal:  Oncogene       Date:  2002-03-27       Impact factor: 9.867

9.  Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression.

Authors:  P K Epling-Burnette; J H Liu; R Catlett-Falcone; J Turkson; M Oshiro; R Kothapalli; Y Li; J M Wang; H F Yang-Yen; J Karras; R Jove; T P Loughran
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

10.  PTEN is a negative regulator of STAT3 activation in human papillomavirus-infected cells.

Authors:  Shishinn Sun; Bettie M Steinberg
Journal:  J Gen Virol       Date:  2002-07       Impact factor: 3.891

View more
  18 in total

1.  The role of the c-Jun N-terminal kinase 2-α-isoform in non-small cell lung carcinoma tumorigenesis.

Authors:  R T Nitta; C A Del Vecchio; A H Chu; S S Mitra; A K Godwin; A J Wong
Journal:  Oncogene       Date:  2010-09-27       Impact factor: 9.867

Review 2.  The R(h)oads to Stat3: Stat3 activation by the Rho GTPases.

Authors:  Leda Raptis; Rozanne Arulanandam; Mulu Geletu; James Turkson
Journal:  Exp Cell Res       Date:  2011-05-18       Impact factor: 3.905

3.  Effect of ouabain on myocardial ultrastructure and cytoskeleton during the development of ventricular hypertrophy.

Authors:  Shao-hua Zhao; Hai-qing Gao; Xiang Ji; Yan Wang; Xiang-ju Liu; Bei-an You; Xiao-pei Cui; Jie Qiu
Journal:  Heart Vessels       Date:  2012-01-13       Impact factor: 2.037

Review 4.  Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.

Authors:  Carolien Boeckx; Marc Baay; An Wouters; Pol Specenier; Jan B Vermorken; Marc Peeters; Filip Lardon
Journal:  Oncologist       Date:  2013-07-02

5.  Silencing SOCS3 could inhibit TNF-α induced apoptosis in 3T3-L1 and mouse preadipocytes.

Authors:  Xia Zhao; Renli Qi; Chao Sun; Yunfei Xie
Journal:  Mol Biol Rep       Date:  2012-06-20       Impact factor: 2.316

6.  Association of SP1 rs1353058818 and STAT3 rs1053004 gene polymorphisms with human tongue squamous cell carcinoma.

Authors:  Heqing Lai; Guochao Xu; Haifeng Meng; Haiying Zhu
Journal:  Biosci Rep       Date:  2019-07-23       Impact factor: 3.840

7.  Inhibition of STAT-3 results in radiosensitization of human squamous cell carcinoma.

Authors:  James A Bonner; Hoa Q Trummell; Christopher D Willey; Brian A Plants; Kevin P Raisch
Journal:  Radiother Oncol       Date:  2009-07-16       Impact factor: 6.280

Review 8.  Engaged for survival: From cadherin ligation to STAT3 activation.

Authors:  Mulu Geletu; Stephanie Guy; Rozanne Arulanandam; Hélène Feracci; Leda Raptis
Journal:  JAKSTAT       Date:  2013-12-06

9.  New basic approach to treat non-small cell lung cancer based on RNA-interference.

Authors:  Christina Makowiecki; Andrea Nolte; Besmire Sutaj; Timea Keller; Meltem Avci-Adali; Heidi Stoll; Christian Schlensak; Hans Peter Wendel; Tobias Walker
Journal:  Thorac Cancer       Date:  2014-03-03       Impact factor: 3.500

10.  Differential epidermal growth factor receptor signaling regulates anchorage-independent growth by modulation of the PI3K/AKT pathway.

Authors:  J O Humtsoe; R H Kramer
Journal:  Oncogene       Date:  2009-11-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.